627095-94-7

Upstream product

• 229980-47-6 methyl 2-(4-bromophenoxy)-2-methylpropanoate 
• 1350846-81-9 methyl 2-[4-(2-heptanoylaminoethyl)phenoxy]-2-methylpropanoate 
• 1350846-97-7 methyl 2-[4-(2-phthalimidoethen-2-yl)phenoxy]-2-methylpropanoate 
• 1350846-89-7 methyl 2-[4-(2-phthalimidoethyl)phenoxy]-2-methylpropanoate 
• 190182-03-7 methyl 2-[4-(2-aminoethyl)phenoxy]-2-methylpropanoate 
• 1350846-93-3 methyl 2-[4-(2-heptylaminoethyl)phenoxy]-2-methylpropanoate 
• 1350846-85-3 methyl 2-(4-{2-[N-(heptyl)-N-(benzoxazol-2-yl)amino]ethyl}phenoxy)-2-methylpropanoate 
• 106-41-2 4-bromo-phenol 
• 7472-69-7 2-(4-bromophenoxy)-2-methylpropanoic acid 

Relevant academic research and scientific papers

Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity

A series of ureidofibrate-like derivatives was prepared and assayed for their PPAR functional activity. A calorimetric approach was used to characterize PPARγ-ligand interactions, and docking experiments and X-ray studies were performed to explain the obs

Benzoxazole compound and pharmaceutical composition containing the same

The present invention is directed to a benzoxazole compound represented by the following formula (1): (wherein R1represents an alkyl group, a C6-10aryl-C1-8alkyl group, etc.; each of R2and R3, which a